CIVCO Medical Solutions has launched a new stereotactic radiosurgery (SRS) and stereotactic fractionated radiation (SRT) solution for head and brain tumors.
The non-invasive device, trUpoint ARCH, is a frameless solution designed to stabilize a patient's head in a comfortable hold for delivering high radiation doses.
Using precisely shaped beams, stereotactic radiosurgery delivers high doses of radiation to destroy the tumor and minimize exposure of the radiation to surrounding healthy tissues and organs.
Indexing is available on the device, nasion, and the arch design allows flexibility in treatment planning around the device, according to the company.
In addition, the device is compatible with the company's Universal Couchtop, Posifix thermoplastic system, AccuForm cushions and Protura Robotic Patient Positioning System to provide a comprehensive motion management solution for effective SRS/SRT treatment.
CIVCO radiation oncology business unit senior vice president and general manager Nat Geissel said, "Our focus when developing new patient positioning and immobilization products is patient comfort and ease of set-up for the clinician; this solution delivers both."
The company said Switzerland-based University Hospital Zurich began using trUpoint ARCH with radiosurgery program in late January 2013.
